Literature DB >> 6018280

Potentiation of anticoagulant effect of warfarin by phenylbutazone.

P M Aggeler, R A O'Reilly, L Leong, P E Kowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6018280     DOI： 10.1056/NEJM196703022760904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  47 in total

1.  Some clinical implications of the protein binding of digoxin.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.

Authors:  F V Fossella; S M Lippman; D E Seitz; D S Alberts; C W Taylor; E Wiltshaw; J Hardy; M O'Brien; T R Haynes; R L Wolen
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

Review 3.  Anticoagulants in older patients. A safety perspective.

Authors:  R J Beyth; C S Landefeld
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

4.  Studies of the interaction of carbenoxolone sodium and warfarin sodiun in vivo [proceedings].

Authors:  S Gottfried; D V Parke; P J Sacra; P C Thornton
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

5.  Interaction between azapropazone and warfarin.

Authors:  P R Powell-Jackson
Journal:  Br Med J       Date:  1977-05-07

Review 6.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

7.  Clinical experience with an oral anticoagulant in children.

Authors:  U Carpentieri; Q X Nghiem; L C Harris
Journal:  Arch Dis Child       Date:  1976-06       Impact factor: 3.791

8.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 9.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 10.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.